• Skip to main content
  • Skip to footer

Oklahoma Medical Research Foundation | OMRF

  • About
    • General Information
    • Disease Research
    • Training & Outreach
    • Events
    • Careers
    • Contact Us
  • Science
    • Scientist Directory
    • Research Programs
    • Research Centers
    • Core Facilities
    • Scientific Publications
    • Scientific Seminars
    • Technology Ventures
  • News
    • Media Resources
    • News Releases
    • Publications
    • On Your Health
    • Bodywork
  • Patients
    • Anti Aging Study
    • Lupus (SLE)
    • MBTPS1 Related Disorders
    • Multiple Sclerosis
    • Rheumatoid Arthritis
    • Sarcoidosis
    • Sjögren’s Disease
    • Osteoarthritis
    • Other Autoimmune Disorders
  • Donate
    • Donate Now
    • Ways to Give
    • Tax Credit
    • Planned Giving
    • Contact Philanthropy
Home - OMRF News - Archives for glioblastoma

glioblastoma

PC schools donate more than $100,000 to OMRF

June 25, 2024

District has held fundraisers for OMRF since 1975

Filed Under: News Tagged With: diffuse intrinsic pontine glioma, glioblastoma, Linda Thompson, lois thomas, Oklahoma Medical Research Foundation, OMRF, PC Cancer Classic, PC Schools, scientist-news

2020 Annual Report: Old Drug, New Tricks

The road from laboratory discoveries to drugs to treat patients might more accurately be described as a treacherous mountain path. Many experiments that appear promising in a Petri dish don’t work in mice. And compounds that are safe and effective in rodents won’t necessarily prove out in people. The U.S. drug industry’s trade organization, the […]

Beating The Odds

Brain cancer survivor Mike Schuster celebrates a milestone he never thought possible.

OMRF doctors make potential breakthrough in brain cancer treatment

September 16, 2020

Doctors at the Oklahoma Medical Research Foundation are celebrating what could become a breakthrough in brain cancer treatment.

Filed Under: Videos Tagged With: cancer, dipg, FDA, glioblastoma, Oklahoma Medical Research Foundation, OKN-007, OMRF, pediatric, Rheal, scientist-news, Towner, treatment

OMRF brain tumor drug receives rare disease designations from the FDA

September 2, 2020

The drug treats fast-growing, deadly brain cancers with no effective treatment.

Filed Under: News, Technology Ventures News Tagged With: 007, administration, approval, bob, Bob Floyd, brain cancer, cancer, center, childhood, diffuse intrinsic pontine glioma, dipg, drug, FDA, Floyd, glioblastoma, glioma, Oblato, Oklahoma Medical Research Foundation, okn, OKN-007, OKN007, OMRF, OUHSC, pediatric, rare pediatric disease designation, Rheal, robert, rpdd, scientist-news, stephenson, Towner

New use for OMRF brain cancer treatment could extend lives

December 18, 2019

In a new study, the OMRF compound OKN-007 is being combined with the current standard-of-care medication for glioblastoma.

Filed Under: News, Technology Ventures News Tagged With: battiste, brain cancer, cancer, center, chemo, drug, glioblastoma, James, Manu Nair, newsok, OKC, Oklahoma Medical Research Foundation, OKN-007, OMRF, ou, OUHSC, patient, Rheal, scientist-news, stephenson, technology ventures, temodar, therapy, Towner, treatment, university of oklahoma

  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Go to Next Page »

Before Footer

Equal Opportunity Employer

Footer

  • Jobs
  • Directory
  • Donor Privacy Statement
  • Ethics Point
  • Intranet
Facebook Twitter Instagram Linkedin

Subscribe to OMRF News
  • Contact
  • Careers
  • Donor Privacy
  • Ethics Point
  • Intranet
OMRF Logo
OKLAHOMA MEDICAL RESEARCH FOUNDATION
825 NE 13th St.
Oklahoma City, OK 73104
(405) 271-6673
Charity navigatorUnited WayTop Workplace